The latest board meeting for Cardiff Oncology Inc took place on 15 May 2026, for the purpose of Cardiff Oncology Inc First Quarter Earnings Results for 2026See details
Cardiff Oncology Inc has a share price target of US$ 8, revenue growth forecast of -40.7%, and profit growth estimate of -4.8% for FY26, based on top 8 analyst calls.